메뉴 건너뛰기




Volumn 209, Issue 7, 2012, Pages 1235-1239

The challenges and promises of new therapies for cystic fibrosis

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

EID: 84864297297     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121248     Document Type: Short Survey
Times cited : (50)

References (31)
  • 1
    • 70350144293 scopus 로고    scopus 로고
    • Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production
    • Byrd, M.S., I. Sadovskaya, E. Vinogradov, H. Lu, A.B. Sprinkle, S.H. Richardson, L. Ma, B. Ralston, M.R. Parsek, E.M. Anderson, et al. 2009. Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol. Microbiol. 73:622-638. http://dx.doi.org/ 10.1111/j.1365-2958.2009.06795.x
    • (2009) Mol. Microbiol , vol.73 , pp. 622-638
    • Byrd, M.S.1    Sadovskaya, I.2    Vinogradov, E.3    Lu, H.4    Sprinkle, A.B.5    Richardson, S.H.6    Ma, L.7    Ralston, B.8    Parsek, M.R.9    Anderson, E.M.10
  • 2
    • 40649112565 scopus 로고    scopus 로고
    • Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis
    • Campodónico, V.L., M. Gadjeva, C. Paradis-Bleau, A. Uluer, and G.B. Pier. 2008. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol. Med. 14:120-133. http://dx.doi.org/ 10.1016/j.molmed.2008.01.002
    • (2008) Trends Mol. Med. , vol.14 , pp. 120-133
    • Campodónico, V.L.1    Gadjeva, M.2    Paradis-Bleau, C.3    Uluer, A.4    Pier, G.B.5
  • 3
    • 47049095809 scopus 로고    scopus 로고
    • Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
    • Clunes, M.T., and R.C. Boucher. 2007. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discov. Today Dis. Mech. 4:63-72. http://dx.doi.org/10.1016/j.ddmec.2007.09.001
    • (2007) Drug Discov. Today Dis. Mech , vol.4 , pp. 63-72
    • Clunes, M.T.1    Boucher, R.C.2
  • 4
    • 84859620802 scopus 로고    scopus 로고
    • Cystic fibrosis: a mucosal immunodeficiency syndrome
    • Cohen, T.S., and A. Prince. 2012. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18:509-519. http://dx.doi.org/ 10.1038/nm.2715
    • (2012) Nat. Med. , vol.18 , pp. 509-519
    • Cohen, T.S.1    Prince, A.2
  • 7
    • 79953700578 scopus 로고    scopus 로고
    • New horizons in the treatment of cystic fibrosis
    • Cuthbert, A.W. 2011. New horizons in the treatment of cystic fibrosis. Br. J. Pharmacol. 163:173-183. http://dx.doi.org/10.1111/j.1476-5381.2010.01137.x
    • (2011) Br. J. Pharmacol. , vol.163 , pp. 173-183
    • Cuthbert, A.W.1
  • 8
    • 70349223856 scopus 로고    scopus 로고
    • Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion
    • Garcia, M.A., N. Yang, and P.M. Quinton. 2009. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J. Clin. Invest. 119:2613-2622. http://dx.doi.org/10.1172/JCI38662
    • (2009) J. Clin. Invest. , vol.119 , pp. 2613-2622
    • Garcia, M.A.1    Yang, N.2    Quinton, P.M.3
  • 9
    • 79961042398 scopus 로고    scopus 로고
    • Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture
    • Ghafoor, A., I.D. Hay, and B.H.A. Rehm. 2011. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl. Environ. Microbiol. 77:5238-5246. http://dx.doi.org/10.1128/AEM.00637-11
    • (2011) Appl. Environ. Microbiol. , vol.77 , pp. 5238-5246
    • Ghafoor, A.1    Hay, I.D.2    Rehm, B.H.A.3
  • 10
    • 79953215718 scopus 로고    scopus 로고
    • Current status and future directions of gene and cell therapy for cystic fibrosis
    • Griesenbach, U., and E.W. Alton. 2011. Current status and future directions of gene and cell therapy for cystic fibrosis. BioDrugs. 25:77-88. http://dx.doi.org/10.2165/11586960-000000000-00000
    • (2011) BioDrugs , vol.25 , pp. 77-88
    • Griesenbach, U.1    Alton, E.W.2
  • 13
    • 71549131283 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa: a formidable and ever-present adversary
    • Kerr, K.G., and A.M. Snelling. 2009. Pseudomonas aeruginosa: a formidable and ever-present adversary. J. Hosp. Infect. 73:338-344. http://dx.doi.org/10.1016/j.jhin.2009.04.020
    • (2009) J. Hosp. Infect , vol.73 , pp. 338-344
    • Kerr, K.G.1    Snelling, A.M.2
  • 14
    • 0023739855 scopus 로고
    • Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4
    • Kocharova, N.A., Y.A. Knirel, A.S. Shashkov, N.K. Kochetkov, and G.B. Pier. 1988. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. J. Biol. Chem. 263:11291-11295.
    • (1988) J. Biol. Chem. , vol.263 , pp. 11291-11295
    • Kocharova, N.A.1    Knirel, Y.A.2    Shashkov, A.S.3    Kochetkov, N.K.4    Pier, G.B.5
  • 15
    • 72449194729 scopus 로고    scopus 로고
    • Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia
    • Koh, A.Y., G.P. Priebe, C. Ray, N. Van Rooijen, and G.B. Pier. 2009. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 77:5300-5310. http://dx.doi.org/10.1128/IAI.00501-09
    • (2009) Infect. Immun. , vol.77 , pp. 5300-5310
    • Koh, A.Y.1    Priebe, G.P.2    Ray, C.3    Van Rooijen, N.4    Pier, G.B.5
  • 16
    • 0034099054 scopus 로고    scopus 로고
    • The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosa
    • Massengale, A.R., F.J. Quinn, A. Williams, S. Gallagher, and S.C. Aronoff. 2000. The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosa. Exp. Lung Res. 26:163-178. http://dx.doi.org/10.1080/019021400269853
    • (2000) Exp. Lung Res. , vol.26 , pp. 163-178
    • Massengale, A.R.1    Quinn, F.J.2    Williams, A.3    Gallagher, S.4    Aronoff, S.C.5
  • 17
  • 18
    • 77954644239 scopus 로고    scopus 로고
    • Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
    • Oliver, A., and A. Mena. 2010. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16:798-808. http://dx.doi.org/10.1111/j.1469-0691.2010.03250.x
    • (2010) Clin. Microbiol. Infect. , vol.16 , pp. 798-808
    • Oliver, A.1    Mena, A.2
  • 20
    • 0023220464 scopus 로고
    • Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients
    • Pier, G.B., J.M. Saunders, P. Ames, M.S. Edwards, H. Auerbach, J. Goldfarb, D.P. Speert, and S. Hurwitch. 1987. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients. N. Engl. J. Med. 317:793-798. http://dx.doi.org/10.1056/ NEJM198709243171303
    • (1987) N. Engl. J. Med. , vol.317 , pp. 793-798
    • Pier, G.B.1    Saunders, J.M.2    Ames, P.3    Edwards, M.S.4    Auerbach, H.5    Goldfarb, J.6    Speert, D.P.7    Hurwitch, S.8
  • 22
    • 48149090717 scopus 로고    scopus 로고
    • Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis
    • Quinton, P.M. 2008. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet. 372:415-417. http://dx.doi.org/10.1016/S0140-6736(08)61162-9
    • (2008) Lancet , vol.372 , pp. 415-417
    • Quinton, P.M.1
  • 24
    • 84861780622 scopus 로고    scopus 로고
    • Immune responses in cystic fibrosis: are they intrinsically defective? Am
    • Ratner, D., and C. Mueller. 2012. Immune responses in cystic fibrosis: are they intrinsically defective? Am. J. Respir. Cell Mol. Biol. 46:715-722. http://dx.doi.org/10.1165/rcmb.2011-0399RT
    • (2012) J. Respir. Cell Mol. Biol. , vol.46 , pp. 715-722
    • Ratner, D.1    Mueller, C.2
  • 25
    • 84862317515 scopus 로고    scopus 로고
    • Hypertonic saline in treatment of pulmonary disease in cystic fibrosis
    • Reeves, E.P., K. Molloy, K. Pohl, and N.G. McElvaney. 2012. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal. 2012:465230. http://dx.doi.org/10.1100/2012/465230
    • (2012) ScientificWorldJournal , vol.2012 , pp. 465230
    • Reeves, E.P.1    Molloy, K.2    Pohl, K.3    McElvaney, N.G.4
  • 26
    • 34147134534 scopus 로고    scopus 로고
    • Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor
    • Reiniger, N., M.M. Lee, F.T. Coleman, C. Ray, D.E. Golan, and G.B. Pier. 2007. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun. 75:1598-1608. http://dx.doi.org/10.1128/ IAI.01980-06
    • (2007) Infect. Immun. , vol.75 , pp. 1598-1608
    • Reiniger, N.1    Lee, M.M.2    Coleman, F.T.3    Ray, C.4    Golan, D.E.5    Pier, G.B.6
  • 27
    • 80052689527 scopus 로고    scopus 로고
    • Healthrelated quality of life in cystic fibrosis
    • Royce, F.H., and J.C. Carl. 2011. Healthrelated quality of life in cystic fibrosis. Curr. Opin. Pediatr. 23:535-540. http://dx.doi.org/10.1097/MOP.0b013e32834a7829
    • (2011) Curr. Opin. Pediatr , vol.23 , pp. 535-540
    • Royce, F.H.1    Carl, J.C.2
  • 30
    • 79958069364 scopus 로고    scopus 로고
    • The airway microbiome in cystic fibrosis and implications for treatment
    • Zemanick, E.T., S.D. Sagel, and J.K. Harris. 2011. The airway microbiome in cystic fibrosis and implications for treatment. Curr. Opin. Pediatr. 23:319-324. http://dx.doi.org/10.1097/ MOP.0b013e32834604f2
    • (2011) Curr. Opin. Pediatr. , vol.23 , pp. 319-324
    • Zemanick, E.T.1    Sagel, S.D.2    Harris, J.K.3
  • 31
    • 0028557095 scopus 로고
    • Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR
    • Zhou, L., C.R. Dey, S.E. Wert, M.D. DuVall, R.A. Frizzell, and J.A. Whitsett. 1994. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 266:1705-1708. http://dx.doi.org/10.1126/science.7527588
    • (1994) Science , vol.266 , pp. 1705-1708
    • Zhou, L.1    Dey, C.R.2    Wert, S.E.3    DuVall, M.D.4    Frizzell, R.A.5    Whitsett, J.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.